NTR Nutrien Ltd.
$69.42▲ +1.37%
Materials
Other
After hours
$69.39▼ -0.04%
Oct 30, 5:10 PM ET
Volume 1.41M
Avg Volume (10D) 2.54M
Key Metrics & Fundamentals
Market Cap
$33.13B
P/E Ratio
14.1
Div Yield
3.21%
52W Range
53.03 - 85.36
% vs 50 MA
-5.06%
% vs 200 MA
-2.35%
RSI-14
46.6
MACD Histogram
+0.1600
Beta (1Y vs SPY)
-0.27
Free Cash Flow
$1.99B
Gross Rev
$10.81B
Gross Profit
$3.25B
EBITDA
$2.49B
COGS
$7.56B
Operating Exp
$1.26B
Operating Income
$1.99B
EBIT
$1.99B
Pretax Income
$1.60B
Net Income
$1.21B
EPS (Diluted)
2.53
Price & Volume History
Loading chart…
Recent News

3 Canadian Undervalued Stocks Trading Up To 50% Below Fair Value
Simply Wall St. · Oct 29, 2026 11:18 PM ET

Earnings Preview: Nutrien (NTR) Q3 Earnings Expected to Decline
Zacks · Oct 28, 2026 9:00 AM ET

Elite Canadian Value Stocks To Own In October 2026
Simply Wall St. · Oct 28, 2026 3:12 AM ET
This Canadian fertilizer stock is standing firm amid market volatility
Investing.com · Oct 27, 2026 9:30 AM ET
UBS Adjusts Price Target on Nutrien to $62 From $59, Maintains Sell Rating
MT Newswires · Oct 27, 2026 9:22 AM ET

3 Canadian Undervalued Stocks To Own In October 2026
Simply Wall St. · Oct 27, 2026 2:08 AM ET

What Is Going On With CF Industries Stock?
Trefis · Oct 26, 2026 6:38 PM ET

What Is Going On With Nutrien Stock?
Trefis · Oct 26, 2026 6:04 PM ET
Oppenheimer Trims Price Target on Nutrien to $78 From $80, Keeps Outperform Rating
MT Newswires · Oct 22, 2026 8:39 AM ET

Nutrien Announces Release Dates for Third Quarter 2026 Results and Conference Call
Business Wire · Oct 15, 2026 12:00 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NTR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.